MX9803345A - 24-homo-26,27-hexafluoro-colecalciferoles. - Google Patents

24-homo-26,27-hexafluoro-colecalciferoles.

Info

Publication number
MX9803345A
MX9803345A MX9803345A MX9803345A MX9803345A MX 9803345 A MX9803345 A MX 9803345A MX 9803345 A MX9803345 A MX 9803345A MX 9803345 A MX9803345 A MX 9803345A MX 9803345 A MX9803345 A MX 9803345A
Authority
MX
Mexico
Prior art keywords
formula
compounds
agents
hydrogen
useful
Prior art date
Application number
MX9803345A
Other languages
English (en)
Inventor
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9803345A publication Critical patent/MX9803345A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48Halogenated derivatives
    • C07C35/52Alcohols with a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invencion se refiere a un compuesto de la formula (I), donde A es un enlace doble de carbono con la configuracion esteroquímica E o Z, es decir, de la formula (II), respectivamente, R es hidroxi y R1 es hidrogeno, o =CH2, o R es hidrogeno o fluoro y R1 es =CH2. Los compuestos de la formula I estimulan la diferenciacion e inhibicion de la proliferacion de ciertas líneas celulares de cáncer y de la piel. Por consiguiente, los compuestos de la formula I son utiles como agentes para el tratamiento de enfermedades proliferativas de la piel, tal como la psoriasis. Los compuestos de la formula I son también utiles como agentes para el tratamiento de enfermedades neoplásticas, tales como la leucemia.
MX9803345A 1995-10-31 1998-04-28 24-homo-26,27-hexafluoro-colecalciferoles. MX9803345A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US712595P 1995-10-31 1995-10-31

Publications (1)

Publication Number Publication Date
MX9803345A true MX9803345A (es) 1998-09-30

Family

ID=21724362

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9803345A MX9803345A (es) 1995-10-31 1998-04-28 24-homo-26,27-hexafluoro-colecalciferoles.

Country Status (9)

Country Link
EP (1) EP0874813A1 (es)
JP (1) JPH10512297A (es)
KR (1) KR19990067173A (es)
CN (1) CN1201452A (es)
AU (1) AU7297496A (es)
CA (1) CA2235584A1 (es)
MX (1) MX9803345A (es)
WO (1) WO1997016423A1 (es)
ZA (1) ZA968953B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114276284A (zh) * 2021-12-30 2022-04-05 正大制药(青岛)有限公司 一种氟骨化醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
EP0972762B1 (en) * 1993-07-09 2003-10-01 Laboratoire Theramex Novel structural analogues of vitamin D

Also Published As

Publication number Publication date
WO1997016423A1 (en) 1997-05-09
ZA968953B (en) 1997-07-30
KR19990067173A (ko) 1999-08-16
JPH10512297A (ja) 1998-11-24
EP0874813A1 (en) 1998-11-04
CN1201452A (zh) 1998-12-09
AU7297496A (en) 1997-05-22
CA2235584A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
AU686251B2 (en) Vitamin D3 analogs
GR3029449T3 (en) (e)-20(22)-dehydrovitamin d compounds
AU3887797A (en) Pentafluorobenzenesulfonamides and analogs
ZA975439B (en) New pyridyl alkane acid amides.
MX9700429A (es) El uso de compuestos de tiazol y tiadiazol.
GR3021833T3 (es)
MY117381A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
MX9803966A (es) 25-hidroxi-16-en-26,27-bishomo-colecalciferoles.
HUT74942A (en) New conversion of bisnoralcohol to bisnoraldehyde
YU13499A (sh) Primena 1-hidroksi-2-piridona za lečenje seboroitičnog dermatitisa
MX9803345A (es) 24-homo-26,27-hexafluoro-colecalciferoles.
AU626470B2 (en) Benzocycloalkylaminopyridinamines and related compounds, a process and intermediates for their preparation and their use as medicaments
MX9702139A (es) Derivados de 1,25-dihidroxi-16,22,23-trisdeshidro-colecalciferol.
AU586477B2 (en) Hexenoic acids
CA2062520A1 (en) Synthesis of 1-Alpha-Hydroxy-Secosterol Compounds
GR3023031T3 (en) Process for producing imidazole derivative
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
MX9603797A (es) Agentes terapeuticos para su uso en la terapia del cancer.
ECSP972061A (es) Derivados de 1,25 -dihidroxi-16, 22, 23-trien - colecalciferol
MX9605415A (es) Derivado de propiofenona y procedimientos para preparar el mismo.